Peetharohini mathirai kalikkam and Avarai choornam for Vellezhuthu.

A clinical study on the effect of Peetharohini Mathirai Kalikkam (Ophthalmic application) and Avarai Choornam (Internal ) in the treatment of Vellezhuthu (Presbyopia)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/028815

Enrollment

Registered

2020-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H524- Presbyopia

Interventions

Intervention1: Peetharohini Mathirai Kalikkam (Ophthalmic application) Avarai Choornam (Internal): Peetharohini Mathirai Kalikkam (Ophthalmic application) - 2 Drops instilled into each eye, twice a

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of vellezhuthu (Presbyopia) according to Siddha and Modern Science. Patients having power of eye within 2.5 Diopter

Exclusion criteria

Exclusion criteria: Any other lenticular or coeneal opacity. History of previous eye surgery Hypertension Diabetic Mellitus Other serious systemic illness Disoders of head that causes redness, discomfert, diminished vision, discharge, pain in the eyes.

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptoms. Distant vision by snells lens distant vision chart Near vision by Jaegers chart Near point of convergence Reduction in the power of required lens Timepoint: 48 days	—

Secondary

Measure	Time frame
Microbial load of peetharohini mathirai by sterility test by pour plate method. Physiochemical analysis of Peetharohini Mathirai Analysis of heavy metals and pesticides.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactDr D Periyasami

National Institute Of Siddha

sami2011nis@gmail.com7358481734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026